Researcher
Thomas Voets
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Physiology
- See also: Thomas Voets (Flanders Institute for Biotechnology)
Affiliations
- Laboratory of Ion Channel Research (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2012 → Today - Voets Lab (Research group)
Responsible
From1 Jul 2017 → Today - Laboratory of Ion Channel Research (VIB-KU Leuven) (Division)
Member
From1 Oct 2007 → Today - Faculty of Medicine (Faculty)
Member
From1 Oct 2002 → 30 Sep 2003
Projects
1 - 10 of 57
- The role of TRPM3 in the development of pathological pain - from the periphery to the brainFrom1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mechanisms and consequences of signaling via ion channels in the bladder wall.From1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting TRP channels to relief painFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization of a disease model for a TRPM3 channelopathy causing developmental and epileptic encephalopathiesFrom9 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A TRiP to the dorsal root ganglia: Unraveling the molecular characterization of the still neglected satellite glial cells.From1 Oct 2022 → TodayFunding: FWO senior postdoctoral fellowship
- A multimodal non-linear optical platform for 2|3-photon excitation and 2nd|3rd harmonic imaging deep inside living tissues and animalsFrom1 May 2022 → TodayFunding: FWO Large scale research infrastructure
- Development of a sensor testing platform based on cell culturing and microfluidic technologies.From12 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimizing TRP channels for use as stable thermosensorsFrom19 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Role of TRP channels in bladder (dys)functionFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validation of TRPM3 as a target for neuropathic painFrom1 Oct 2021 → 31 Dec 2023Funding: IOF - technology validation in lab
Publications
11 - 20 of 231
- Machine learning-assisted fluoroscopy of bladder function in awake mice(2022)
Authors: Helene De Bruyn, Sebastian Munck, Wouter Everaerts, Thomas Voets
- Loratadine, an antihistaminic drug, suppresses the proliferation of endometrial stromal cells by inhibition of TRPV2(2022)
Authors: Katrien De Clercq, Sara Kerselaers, Thomas Voets, Joris Vriens
- Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop(2022)
Authors: Kathi Held, Davide Aloi, Annelies Janssens, Thomas Voets, Joris Vriens
Pages: 3560 - 3575 - The role of the TRP channels in the defense against bacterial urinary tract infections.(2022)
Authors: Noémie Luyts, Wouter Everaerts, Thomas Voets
- Videocystometry, a novel approach to study the murine lower urinary tract(2022)
Authors: Helene De Bruyn, Wouter Everaerts, Thomas Voets
- Phenotypic spectrum of the recurrent TRPM3 p.(Val837Met) substitution in seven individuals with global developmental delay and hypotonia(2022)
Authors: Thomas Voets, Joris Vriens
Pages: 1667 - 1675 - TRP channels in lower urinary tract function(2022)
Authors: Matthias Vanneste, Wouter Everaerts, Thomas Voets
- NEW TECHNIQUE FOR VIDEO URODYNAMICS IN MICE ALLOWS NEW INSIGHTS INTO THE ROLE OF ION CHANNEL TRPV4 IN THE MURINE LOWER URINARY TRACT(2022)
Authors: Thomas Voets, Wouter Everaerts
Pages: E859 - E859 - TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma(2022)
Authors: Katrien De Clercq, Daniela Annibali, Frédéric Amant, Sileny Han, Els Van Nieuwenhuysen, Thaïs Baert, Karen Peeraer, Thomas Voets, Toon Van Gorp, Joris Vriens
- TRPM3 Is Expressed in Afferent Bladder Neurons and Is Upregulated during Bladder Inflammation.(2021)
Authors: Matthias Vanneste, Marie Mulier, Thomas Voets, Wouter Everaerts
Patents
1 - 4 of 4
- Aryl derivatives for treating trpm3 mediated disorders (Inventor)
- Heterocycle derivatives for treating trpm3 mediated disorders (Inventor)
- Screening method for analgesic agents (Inventor)
- Treatment of pain (Inventor)